These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 19046847)

  • 1. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis.
    Houvenaeghel G; Nos C; Giard S; Mignotte H; Esterni B; Jacquemier J; Buttarelli M; Classe JM; Cohen M; Rouanet P; Penault Llorca F; Bonnier P; Marchal F; Garbay JR; Fraisse J; Martel P; Fondrinier E; Tunon de Lara C; Rodier JF
    Eur J Surg Oncol; 2009 Jul; 35(7):690-5. PubMed ID: 19046847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node.
    Schrenk P; Konstantiniuk P; Wölfl S; Bogner S; Haid A; Nemes C; Jagoutz-Herzlinger M; Redtenbacher S
    Br J Surg; 2005 Jun; 92(6):707-13. PubMed ID: 15810047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
    Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: nomogram validation and comparison with other models.
    Houvenaeghel G; Bannier M; Nos C; Giard S; Mignotte H; Jacquemier J; Martino M; Esterni B; Belichard C; Classe JM; Tunon de Lara C; Cohen M; Payan R; Blanchot J; Rouanet P; Penault-Llorca F; Bonnier P; Fournet S; Agostini A; Marchal F; Garbay JR
    Breast; 2012 Apr; 21(2):204-9. PubMed ID: 22014859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases.
    Leidenius MH; Vironen JH; Riihelä MS; Krogerus LA; Toivonen TS; von Smitten KA; Heikkilä PS
    Eur J Surg Oncol; 2005 Feb; 31(1):13-8. PubMed ID: 15642420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
    Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D
    Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
    Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
    van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
    Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
    Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
    Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement.
    Meretoja TJ; Strien L; Heikkilä PS; Leidenius MH
    Ann Surg Oncol; 2012 Feb; 19(2):567-76. PubMed ID: 21792511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study.
    Coutant C; Rouzier R; Fondrinier E; Marchal F; Guillemin F; Seince N; Rodrigues A; Darai E; Uzan S; Barranger E
    Breast Cancer Res Treat; 2009 Feb; 113(3):537-43. PubMed ID: 18340527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
    Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
    Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node.
    Perhavec A; Perme MP; Hocevar M; Besić N; Zgajnar J
    Breast Cancer Res Treat; 2010 Jan; 119(2):357-66. PubMed ID: 19787449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement--Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer.
    Houvenaeghel G; Nos C; Mignotte H; Classe JM; Giard S; Rouanet P; Lorca FP; Jacquemier J; Bardou VJ;
    J Clin Oncol; 2006 Apr; 24(12):1814-22. PubMed ID: 16567771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.
    Katz A; Smith BL; Golshan M; Niemierko A; Kobayashi W; Raad RA; Kelada A; Rizk L; Wong JS; Bellon JR; Gadd M; Specht M; Taghian AG
    J Clin Oncol; 2008 May; 26(13):2093-8. PubMed ID: 18445838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary lymph node dissection in the case of sentinel lymph node micrometastatic invasion: evaluation of three predictive models.
    Orsoni M; Clerc J; Golfier F; Cortet M; Raudrant D; Krauth JS
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):334-7. PubMed ID: 21669485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node.
    Farshid G; Pradhan M; Kollias J; Gill PG
    Breast; 2004 Dec; 13(6):494-501. PubMed ID: 15563857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.
    Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP
    Breast J; 2005; 11(5):338-43. PubMed ID: 16174155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.